Recently, from a 960-compound screening, quisinostat and other class I HDAC inhibitors are found to suppress growth of diverse SHH signaling inhibitor-resistant clones of mouse medulloblastoma cells [19]. This evidence concerns the gene SHH and medulloblastoma.